Oct 30, 2025 05:59AM TD Cowen Starts DiaMedica Therapeutics Inc. (DMAC) at Buy

Aug 12, 2025 05:12PM DiaMedica Therapeutics Inc. (DMAC) Files $100M Mixed Shelf

Aug 12, 2025 04:15PM DiaMedica Therapeutics Inc. (DMAC) Tops Q2 EPS by 1c

Aug 1, 2025 08:35AM DiaMedica Therapeutics Inc. (DMAC) Files for 8.61M Share Offering by Selling Stockholders

Jul 23, 2025 04:30PM DiaMedica closes $30.1 million private placement of common shares

Jul 21, 2025 08:00AM DiaMedica raises $30 million to fund preeclampsia drug development

Jul 18, 2025 06:38AM DiaMedica Therapeutics Inc. (DMAC) PT Raised to $12 at H.C. Wainwright

May 29, 2025 06:59AM H.C. Wainwright Reiterates Buy Rating on DiaMedica Therapeutics Inc. (DMAC)

May 13, 2025 04:31PM DiaMedica Therapeutics Inc. (DMAC) Tops Q1 EPS by 2c

Mar 19, 2025 06:39AM DiaMedica Therapeutics Inc. (DMAC) PT Raised to $10 at H.C. Wainwright

Feb 24, 2025 08:31AM DiaMedica Therapeutics Inc. (DMAC) Appoints Daniel J. O’Connor to its Board

Feb 20, 2025 08:15AM DiaMedica Therapeutics (DMAC) Announces Publication of DM199’s Mechanism of Action for the Treatment of Acute Ischemic Stroke (AIS) in the Journal Stroke

Nov 13, 2024 04:23PM DiaMedica Therapeutics Inc. (DMAC) Tops Q3 EPS by 1c

Oct 10, 2024 06:57AM H.C. Wainwright Reiterates Buy Rating on DiaMedica Therapeutics Inc. (DMAC)

Oct 9, 2024 08:27AM DiaMedica Therapeutics (DMAC) Announces Regulatory Approval to Begin Phase 2 Trial of DM199 in the Treatment of Preeclampsia

Oct 7, 2024 06:03AM H.C. Wainwright Starts DiaMedica Therapeutics Inc. (DMAC) at Buy

Aug 7, 2024 04:31PM DiaMedica Therapeutics Inc. (DMAC) Tops Q2 EPS by 3c

Jul 10, 2024 04:19PM DiaMedica Therapeutics Inc. (DMAC) Files for 4.72M Share Offering by Selling Stockholders

Jul 1, 2024 08:04AM DiaMedica Therapeutics (DMAC) Announces Closing of $11.8 Million Private Placement

Jun 26, 2024 08:15AM DiaMedica Therapeutics (DMAC) Announces $11.8 Million Private Placement